Injections of semaglutide were associated with significant improvement in cognitive function in people living with HIV (PWH), ...

Brazilian drugmaker Hypera plans to launch next year a generic version of semaglutide, the active ingredient of Novo Nordisk's blockbuster diabetes and weight-loss drug Ozempic, Hypera's chief ...

Researchers analysed data from 150 adults with T1D, divided into semaglutide, tirzepatide, and control groups.

Allurion Technologies (ALUR) announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize ...

A recent study published in Diabetes Technology & Therapeutics has demonstrated that the off-label use of semaglutide and ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...